Unknown

Dataset Information

0

The Impact of Skin Problems on the Quality of Life in Patients Treated with Anticancer Agents: A Cross-Sectional Study.


ABSTRACT: PURPOSE:Patients treated with anticancer agents often experience a variety of treatment-related skin problems, which can impair their quality of life. Materials and Methods:In this cross-sectional study, Dermatology Life Quality Index (DLQI) and clinical information were evaluated in patients under active anticancer treatment using a questionnaire survey and their medical records review. RESULTS:Of 375 evaluated subjects with anticancer therapy, 136 (36.27%) and 114 (30.40%) were treated for breast cancer and colorectal cancer, respectively. We found that women, breast cancer, targeted agent use, and longer duration of anticancer therapy were associated with higher dermatology-specific quality of life distraction. In addition, itching, dry skin, easy bruising, pigmentation, papulopustules on face, periungual inflammation, nail changes, and palmoplantar lesions were associated with significantly higher DLQI scores. Periungual inflammation and palmoplantar lesions scored the highest DLQI. CONCLUSION:We believe our findings can be helpful to clinicians in counseling and managing the patients undergoing anticancer therapy.

SUBMITTER: Lee J 

PROVIDER: S-EPMC6192901 | biostudies-other | 2018 Oct

REPOSITORIES: biostudies-other

altmetric image

Publications

The Impact of Skin Problems on the Quality of Life in Patients Treated with Anticancer Agents: A Cross-Sectional Study.

Lee Jaewon J   Lim Jin J   Park Jong Seo JS   Kim Miso M   Kim Tae-Yong TY   Kim Tae Min TM   Lee Kyung-Hun KH   Keam Bhumsuk B   Han Sae-Won SW   Mun Je-Ho JH   Cho Kwang Hyun KH   Jo Seong Jin SJ  

Cancer research and treatment 20171214 4


<h4>Purpose</h4>Patients treated with anticancer agents often experience a variety of treatment-related skin problems, which can impair their quality of life.<h4>Materials and methods</h4>In this cross-sectional study, Dermatology Life Quality Index (DLQI) and clinical information were evaluated in patients under active anticancer treatment using a questionnaire survey and their medical records review.<h4>Results</h4>Of 375 evaluated subjects with anticancer therapy, 136 (36.27%) and 114 (30.40%  ...[more]

Similar Datasets

| S-EPMC5310898 | biostudies-literature
| S-EPMC5518828 | biostudies-other
| S-EPMC8728463 | biostudies-literature
| S-EPMC6361449 | biostudies-literature
| S-EPMC7646105 | biostudies-literature
| S-EPMC7487577 | biostudies-literature
| S-EPMC9951022 | biostudies-literature
| S-EPMC6196950 | biostudies-literature
| S-EPMC9221244 | biostudies-literature
| S-EPMC7448975 | biostudies-literature